These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3028023)

  • 21. Stimulation of human synovial fibroblast plasminogen activator production by mononuclear cell supernatants.
    Hamilton JA; Slywka J
    J Immunol; 1981 Mar; 126(3):851-5. PubMed ID: 6161965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Steroid stimulation of plasminogen activator production in a human breast cancer cell line (MCF-7).
    Butler WB; Kirkland WL; Gargala TL; Goran N; Kelsey WH; Berlinski PJ
    Cancer Res; 1983 Apr; 43(4):1637-41. PubMed ID: 6682006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth inhibition by progestins in a human endometrial cancer cell line with estrogen-independent progesterone receptors.
    Terakawa N; Hayashida M; Shimizu I; Ikegami H; Wakimoto H; Aono T; Tanizawa O; Matsumoto K; Nishida M
    Cancer Res; 1987 Apr; 47(7):1918-23. PubMed ID: 3815380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex steroid receptors in rheumatoid arthritis.
    Ishizuka M; Hatori M; Suzuki T; Miki Y; Darnel AD; Tazawa C; Sawai T; Uzuki M; Tanaka Y; Kokubun S; Sasano H
    Clin Sci (Lond); 2004 Mar; 106(3):293-300. PubMed ID: 14570589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endorphin and enkephalin ameliorate excessive synovial cell functions in patients with rheumatoid arthritis.
    Takeba Y; Suzuki N; Kaneko A; Asai T; Sakane T
    J Rheumatol; 2001 Oct; 28(10):2176-83. PubMed ID: 11669152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ; Raney S
    Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
    Herman ME; Katzenellenbogen BS
    Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.
    Pietras RJ; Arboleda J; Reese DM; Wongvipat N; Pegram MD; Ramos L; Gorman CM; Parker MG; Sliwkowski MX; Slamon DJ
    Oncogene; 1995 Jun; 10(12):2435-46. PubMed ID: 7784095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
    Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
    Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
    Reiner GC; Katzenellenbogen BS
    Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of biological behaviour of human breast cancer using multiple parameters. A preliminary study.
    Ghosh SN; Seshadri R; Banerji AP; Sampat MB
    Anticancer Res; 1985; 5(4):445-9. PubMed ID: 2994551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential release of plasminogen activator and latent collagenase from mononuclear cell-stimulated synovial cells.
    Golds EE; Ciosek CP; Hamilton JA
    Arthritis Rheum; 1983 Jan; 26(1):15-21. PubMed ID: 6297507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The synovial lining cell: biology and pathobiology.
    Henderson B; Pettipher ER
    Semin Arthritis Rheum; 1985 Aug; 15(1):1-32. PubMed ID: 2994231
    [No Abstract]   [Full Text] [Related]  

  • 34. Secretion of plasminogen activator by rheumatoid and nonrheumatoid synovial cells in culture.
    Berger H
    Arthritis Rheum; 1977; 20(6):1198-205. PubMed ID: 901594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells--role in metastasis.
    Salo T; Liotta LA; Keski-Oja J; Turpeenniemi-Hujanen T; Tryggvason K
    Int J Cancer; 1982 Nov; 30(5):669-73. PubMed ID: 6295970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human synovial fibroblast plasminogen activator. Modulation of enzyme activity by antiinflammatory steroids.
    Hamilton JH; Bootes A; Phillips PE; Slywka J
    Arthritis Rheum; 1981 Oct; 24(10):1296-303. PubMed ID: 7197936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Independence of normal phenotypic properties and cell surface receptor mobility in variant cell lines.
    Williams RE; Linsley PS; Rittenhouse HG; Fox CF; Boone CW
    J Supramol Struct; 1978; 9(2):147-56. PubMed ID: 748674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Responses of human synovial fibroblasts to mononuclear cell factors and retinoic acid.
    Hamilton JA
    Agents Actions Suppl; 1986; 18():47-54. PubMed ID: 2425604
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthesis and secretion of plasminogen activators and collagenases in human cells transformed by Kirsten murine sarcoma virus and N-methyl-N'-nitro-N-nitrosoguanidine.
    Sidhu MK; Kumar S
    Cancer Lett; 1989 Sep; 47(1-2):45-51. PubMed ID: 2561462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The possible role of synovial factors in cartilage destruction.
    Crossley MJ; Connon AM; Hunneyball IM
    Agents Actions Suppl; 1986; 18():39-42. PubMed ID: 3014846
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.